co-infection

Documents about co-infection

• Host Immunity, Plasmodium and Pathogens Co-Infections#471470ClinicalTrials.gov
• Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19#865629ClinicalTrials.gov
• NWRD09 for Persistent Cervical HPV16 Infection#981230ClinicalTrials.gov
• Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India#1409854ClinicalTrials.gov
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection#857957ClinicalTrials.gov
• Long-term Effectiveness and Safety in Hepatitis-co-infected Patients#1407578ClinicalTrials.gov
• A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients#1164945ClinicalTrials.gov
• Treatment of Helminth co-Infection: Short-Term Effects on HIV-1 Progression Markers and Immune Activation#1418391ClinicalTrials.gov
• Mathematical modelling of Hepatitis E Virus (HEV) and Chronic Myeloid Leukemia (CML) co-infection dynamics#956801SU+ Digital Repository
• Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP)#826458ClinicalTrials.gov
• REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection#877899ClinicalTrials.gov
• Phase 2 Study of Yimitasvir Phosphate Capsules#1410564ClinicalTrials.gov
• Phase 3 Study of Yimitasvir Phosphate Capsules#1498925ClinicalTrials.gov
• Immune Responses to Mycobacterium Tuberculosis (Mtb) in People With Latent Tuberculosis Infection With or Without Concomitant Helminth Infection#1443732ClinicalTrials.gov
• SIV infection disrupts the spatial cellular and communication networks of pulmonary granulomas during SIV/Mtb co-infection#222325bioRxiv / medRxiv
• Does infection with Leishmania protect against Covid-19?#357579HAL (France)
• Gene Expression in HIV and Tuberculosis Co-infection#843969ClinicalTrials.gov
• Characterization Of Pantoea ananatis: Population Genomics, Dual-Pathogen Transcriptomics, And Co-Infection Synergy With Burkholderia glumae In Rice#823330LSU Digital Commons
• A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and Hepatitis D Co-infection#1350537ClinicalTrials.gov
• Study of WPV01 Compared With Placebo in Patients With Mild/Moderate COVID-19 Infection#871188ClinicalTrials.gov
• Evaluation of NWRD09 for Female Participants With Persistent HPV16 Infection#1462543ClinicalTrials.gov
• Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study#1008522ClinicalTrials.gov
• C-TST for Diagnosis of Latent Mycobacterium Tuberculosis Infection in Indonesia#1282350ClinicalTrials.gov
• Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With HBeAg Negative HBV/HDV Co-infection#833204ClinicalTrials.gov
• A Pilot Study To Evaluate the Efficacy of Response Guided Therapy of Peginterferon Alfa Plus Ribavirin in the Treatment of Patients With HCV/HBV Co-Infection#861937ClinicalTrials.gov
• Identifying the best method to correct for missing data, a case of HIV/TB co-infection in Kenya#956445SU+ Digital Repository
• HCV Treatment in HIV Co-Infected Patients in Asia#1182989ClinicalTrials.gov
• 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection#454043ClinicalTrials.gov
• Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients#855990ClinicalTrials.gov
• Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection#1244880ClinicalTrials.gov
• A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)#1320029ClinicalTrials.gov
• Safety Study of NBP608 in Healthy Adult Volunteers#325130ClinicalTrials.gov
• Phase I Clinical Trial of a Candidate HPV Vaccine#343705ClinicalTrials.gov
• Clinical Trial of Mica#1094287ClinicalTrials.gov
• Higher-Order Co-Infection on Hypergraphs#1401253arXiv (All)
• Kaletra Monotherapy in HIV/HCV Co-infected Subjects#1337218ClinicalTrials.gov
• Bacterial co-infection and antimicrobial use in hospital-attended patients with laboratory-confirmed influenza infection: a systematic review and meta-analysis.#238046bioRxiv / medRxiv
• Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection#1103566ClinicalTrials.gov
• Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection Patients#1150970ClinicalTrials.gov
• NATURAL HISTORY-Hepatitis C Virus/ Human Immunodeficiency Virus Coinfection#858148ClinicalTrials.gov
• Safety and Immunogenicity of an Inactivated EV71 Vaccine in Infants#287397ClinicalTrials.gov
• Safety, Pharmacokinetics, and Pharmacodynamic Testing of Rabies mAb CBB 1#459957ClinicalTrials.gov
• Functional Cure of Hepatitis B in HIV/HBV Co-infected Patients#883915ClinicalTrials.gov
• NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC#1230861ClinicalTrials.gov
• The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection)#1262553ClinicalTrials.gov
• Phase IV Trial,The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Acute Upper Respiratory Infection#1384289ClinicalTrials.gov
• Revisiting Sour Rot of Grapevine Through Disease-Associated Microbiomes: A Tripartite Co-Infection?#27553HAL (France)
• Visceral leishmaniasis & HIV co-infection in Bangladesh: Investigating prevalence and policy recommendations.#247759NCBI PubMed Central
• Turnip mosaic virus co-opts host RNA methylation to orchestrate plant infection#266285bioRxiv / medRxiv
• Safety of an Inactivated Enterovirus Type 71 Vaccine in Healthy Adults#426639ClinicalTrials.gov